Board Meetings

BSE Code Company Date Purpose
table-arrow 500086 Exide Inds. 30-Apr-2025 Exide Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2025 inter alia to consider and approve the audited financial results of the Company for the financial year ended 31st March 2025 along with the recommendation of final dividend if any on the equity shares for FY 2024-25. Further to our communication dated 21st February 2025 kindly also note that pursuant to SEBI (Prohibition of lnsider Trading) Regulations 2015 read with approved Exide Code of Conduct for Prevention of lnsider Trading the Trading Window for sale/ purchase or any kind of dealing in the securities of the Company is currently closed and shall re-open on 3rd May 2025.
table-arrow 500092 CRISIL 30-Apr-2025 CRISIL Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2025 inter alia to consider and approve the unaudited consolidated and standalone financial results for the first quarter ended March 31 2025 and to consider the payment of first Interim Dividend for the financial year ending December 31 2025.
table-arrow 500123 Elantas Beck 30-Apr-2025 Quarterly Results Elantas Beck India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2025 ,inter alia, to consider and approve Prior Intimation of Board Meeting Scheduled on 30th April, 2025
table-arrow 500249 KSB 30-Apr-2025 KSB Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2025 inter alia to consider and approve the Unaudited Financial Results for the quarter ended on 31st March 2025 of the Company.
table-arrow 500250 L G Balakrishnan 30-Apr-2025 LG Balakrishnan & Bros Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2025 inter alia to consider and approve A meeting of the Board of Directors of the Company is scheduled on Wednesday 30.04.2025 to consider and approve the Audited Financial Results for the quarter and Financial year ended 31.03.2025 and to recommend the dividend if any for the financial year 2024-25.